# Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients

> **NCT03755752** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 65 (actual)

## Conditions studied

- Cataract Diabetic

## Interventions

- **PROCEDURE:** Phacoemulsification with and without Trypan Blue capsule staining

## Key facts

- **NCT ID:** NCT03755752
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-07-25
- **Final completion:** 2018-08-31
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2018-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755752, "Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03755752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*